Neuroprotective role of Beta-asarone: A review
Article Sidebar
-
Beta -Asarone, Parkinson's Disease, Alzheimer's Disease, Neuroprtotecctivity
Abstract
Acorus calamus (Acoraceae) also known as sweet flag in Indian traditional medicine is generally used for treatment of various ailments like cough, fever, bronchitis, inflammation, depression, tumours, haemorrhoids, skin diseases, insomnia, hysteria, epilepsy, and loss of memory. Asarone is a chemical compound of the phenylpropanoid class found in plants such as Acorus and Asarum. There are two isomers, α (trans) and β (cis). Alpha-asarone is potentially toxic compared to beta-asarone and hence pharmacological elucidation of beta-asarone is wide. Beta-asarone due to its blood brain barrier crossing property it is well elucidated for potential neuroprotective effect. The beneficial properties of beta-asarone are attributed to molecular pathways of endoplasmic reticulum stress, autophagy and synaptogenesis through IRE1/XBP1 ER stress pathway, mitochondrial ASK1/MKK7/JNK pathway, CaMKII/CREB/Bcl-2 expression and PERK/CHOP/Bcl-2/Beclin-1 pathways. The memory enhancing property of beta-asarone is said to be due to beclin dependent autophagy by PI3K/AKT/mTOR pathway. The aim of this review is to highlight the neuroprotective role of beta asarone in terms of neuroinflammation, apoptosis, neurogenesis and autophagy with special emphasis on two neurodegenerative disorders Parkinson's disease and Alzheimer's disease along with its beneficial property in elucidating synaptic plasticity and neurogenesis. Further research on toxicity and pharmacokinetics of beta-asarone are much needed to bring this potential compound into therapeutic use.
Full text article
References
Chang, W., Teng, J. 2015. β-asarone prevents Aβ25-35-induced inflammatory responses and autophagy in SH-SY5Y cells: Down expression Beclin-1, LC3B and up expression Bcl-2. International Journal of Clinical and Experimental Medicine, 8(11):20658–20663.
Chellian, R., Pandy, V., Mohamed, Z. 2017. Pharmacology and toxicology of α- and β-Asarone: A review of preclinical evidence. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 32:41–58.
Chen, Y., Wei, G., Nie, H., Lin, Y., Tian, H., Liu, Y., Yu, X., Cheng, S., Yan, R., Wang, Q., Liu, D. H., Deng, W., Lai, Y., Zhou, J. H., Zhang, S. X., Lin, W. W., Chen, D. F. 2014. β-Asarone prevents autophagy and synaptic loss by reducing ROCK expression in asenescence-accelerated prone 8 mice. Brain Research, 1552:41–54.
Deng, M., Huang, L., Ning, B., Wang, N., Zhang, Q., Zhu, C., Fang, Y. 2016. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy. Brain Research, 1652:188–194.
Deng, M., Huang, L., Zhong, X. 2020. β asarone modulates Beclin 1, LC3 and p62 expression to attenuate Aβ40 and Aβ42 levels in APP/PS1 transgenic mice with Alzheimer’s disease. Molecular Medicine Reports, 21(5):2095–2102.
Dong, H., Wu, S., Hu, N., Xing, G. 2018. Efficacy of tenuigenin and β-asarone as augmentations for memantine in the treatment of Alzheimer’s disease. NeuroReport, 29(3):203–207.
Geerts, H., Spiros, A., Roberts, P. 2018. Impact of amyloid-beta changes on cognitive outcomes in Alzheimer’s disease: analysis of clinical trials using a quantitative systems pharmacology model. Alzheimer’s Research and Therapy, 10(1):14.
Geng, Y., Li, C., Liu, J., Xing, G., Zhou, L., Dong, M., Li, X., Niu, Y. 2010. Beta-Asarone Improves Cognitive Function by Suppressing Neuronal Apoptosis in the Beta-Amyloid Hippocampus Injection Rats. Biological and Pharmaceutical Bulletin, 33(5):836–843.
Ghosh, A., Giese, K. P. 2015. Calcium/calmodulin-dependent kinase II and Alzheimer’s disease. Molecular Brain, 8(1):78.
Han, X. J., Hu, Y. Y., Yang, Z. J., Jiang, L. P., Shi, S. L., Li, Y. R., Guo, M. Y., Wu, H. L., Wan, Y. Y. 2017. Amyloid β-42 induces neuronal apoptosis by targeting mitochondria. Molecular Medicine Reports, 16(4):4521–4528.
Huang, L., Deng, M., Fang, Y., Li, L. 2015a. Dynamic changes of five neurotransmitters and their related enzymes in various rat tissues following β-asarone and levodopa co-administration. Experimental and therapeutic medicine, 10(4):1566–1572.
Huang, L., Deng, M., He, Y., Lu, S., Liu, S., Fang, Y. 2016a. β-asarone increases MEF2D and TH levels and reduces α-synuclein level in 6-OHDA-induced rats via regulating the HSP70/MAPK/MEF2D/Beclin-1 pathway: Chaperone-mediated autophagy activation, macroautophagy inhibition and HSP70 up-expression. Behavioural Brain Research, 313:370–379.
Huang, L., Deng, M., He, Y., Lu, S., Ma, R., Fang, Y. 2016b. β-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain. Clinical and Experimental Pharmacology and Physiology, 43(6):634–643.
Huang, L., Deng, M., Zhang, S., Fang, Y., Li, L. 2014. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar. Clinical and Experimental Pharmacology and Physiology, 41(9):685–690.
Huang, L., Deng, M., Zhang, S., Lu, S., Gui, X., Fang, Y. 2017. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson’s rat by enhancing dopa decarboxylase activity. Biomedicine and Pharmacotherapy, 94:666– 678.
Huang, L. P., Deng, M. Z., He, Y. P., Fang, Y. Q. 2015b. β-asarone and levodopa co-administration protects against 6-hydroxydopamine-induced damage in parkinsonian rat mesencephalon by regulating autophagy: down-expression Beclin-1 and light chain 3B and up-expression P62. Clinical and Experimental Pharmacology and Physiology, 42(3):269–277.
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., Lamb, B. T. 2018. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimer’s and Dementia: Translational Research and Clinical Interventions, 4(1):575–590.
Li, C., Xing, G., Dong, M., Zhou, L., Li, J., Wang, G., Zou, D., Wang, R., Liu, J., Niu, Y. 2010. Beta-asarone protection against beta-amyloid-induced neurotoxicity in PC12 cells via JNK signaling and modulation of Bcl-2 family proteins. European Journal of Pharmacology, 635(1-3):96–102.
Liang, Z. H., Cheng, X. H., Ruan, Z. G., Wang, H., Li, S. S., Liu, J., Tian, S. M. 2015. Protective effects of components of the Chinese herb grassleaf sweet flag rhizome on PC12 cells incubated with amyloid-beta42. Neural regeneration research, 10(8):1292.
Lim, H. W., Kumar, H., Kim, B. W., More, S. V., Kim, I. W., Park, J. I., Park, S. Y., Kim, S. K., Choi, D. K. 2014. β-Asarone (cis-2,4,5-trimethoxy-1- allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells. Food and Chemical Toxicology, 72:265–272.
Liu, S. J., Yang, C., Zhang, Y., Su, R. Y., Chen, J. L., Jiao, M. M., Wang, Q. 2016. Neuroprotective effect of β-asarone against Alzheimer’s disease: regulation of synaptic plasticity by increased expression of SYP and GluR1. Drug design, development and therapy, 10:1461–1469.
Liu, W., Zhang, Q., Zhang, J., Pan, W., Zhao, J., Xu, Y. 2017. Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease. Cell and Bioscience, 7(1):19.
Lue, L., Yan, S., Stern, D., Walker, D. 2005. Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimers Disease. Current Drug Target-CNS and Neurological Disorders, 4(3):249– 266.
Ning, B., Deng, M., Zhang, Q., Wang, N., Fang, Y. 2016. β-Asarone Inhibits IRE1/XBP1 Endoplasmic Reticulum Stress Pathway in 6-OHDA-Induced Parkinsonian Rats. Neurochemical Research, 41(8):2097–2101.
Ning, B., Zhang, Q., Deng, M., Wang, N., Fang, Y. 2019a. Endoplasmic reticulum stress induced autophagy in 6-OHDA-induced Parkinsonian rats. Brain Research Bulletin, 146:224–227.
Ning, B., Zhang, Q., Wang, N., Deng, M., Fang, Y. 2019b. β-Asarone Regulates ER Stress and Autophagy Via Inhibition of the PERK/CHOP/Bcl-2/Beclin-1 Pathway in 6-OHDA-Induced Parkinsonian Rats. Neurochemical Research, 44(5):1159– 1166.
Oka, M., Fujisaki, N., Maruko-Otake, A., Ohtake, Y., Shimizu, S., Saito, T., Hisanaga, S.-I., Iijima, K. M., Ando, K. 2017. Ca2+/calmodulin-dependent protein kinase II promotes neurodegeneration caused by tau phosphorylated at Ser262/356 in a transgenic Drosophila model of tauopathy. The Journal of Biochemistry, 162(5):335–342.
Raja, A. E., Vijayalakshmi, M., Devalarao, G. 2009. Acorus calamus Linn.: chemistry and biology. Research Journal of Pharmacy and Technology, 2(2):256-261.
Sinha, A. K., Joshi, B. P., Acharya, R. 2003. Process for the Preparation of Pharmacologically Active α- Asarone from Toxic β-Asarone Rich Acorus Cala- mus Oil. US6590127B1.
Takada, E., Okubo, K., Yano, Y., Iida, K., Someda, M., Hirasawa, A., Yonehara, S., Matsuzaki, K. 2020. Molecular Mechanism of Apoptosis by Amyloid β-Protein Fibrils Formed on Neuronal Cells. ACS Chemical Neuroscience, 11(5):796–805.
Wang, N., Wang, H., Li, L., Li, Y., Zhang, R. 2020. β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer’s Disease. Frontiers in pharmacology, 10:1529.
Wang, W. Y., Tan, M. S., Yu, J. T., Tan, L. 2015. Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Annals of Translational Medicine, 3(10):136.
Wei, G., Chen, Y. B., Chen, D. F., Lai, X. P., Liu, D. H., Deng, R. D., Nie, H. 2013. β-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AβPP/PS1 mice. Journal of Alzheimer’s Disease, 33(3):863– 880.
Xiao, X., Xu, X., Li, F., Xie, G., Zhang, T. 2019. Anti-inflammatory treatment with β-asarone improves impairments in social interaction and cognition in MK-801 treated mice. Brain Research Bulletin, 150:150–159.
Xue, Z., Guo, Y., Zhang, S., Huang, L., He, Y., Fang, R., Fang, Y. 2014. Beta-asarone attenuates amyloid beta-induced autophagy via Akt/mTOR pathway in PC12 cells. European Journal of Pharmacology, 741:195–204.
Yan, S. D., Bierhaus, A., Nawroth, P. P., Stern, D. M. 2009. RAGE and Alzheimer’s Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation? Journal of Alzheimer’s Disease, 16(4):833–843.
Yan, S. S. D., et al. 2012. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer’s disease. Frontiers in Bioscience, S4(1):240.
Yang, C., Li, X., Mo, Y., Liu, S., Zhao, L., Ma, X., Fang, Z., Chen, J., Chen, Y., Yu, X., Fang, S., Zhang, Y., Xian, S., Wang, Q. 2016a. β-Asarone Mitigates Amyloidosis and Downregulates RAGE in a Transgenic Mouse Model of Alzheimer’s Disease. Cellular and Molecular Neurobiology, 36(1):121–130.
Yang, Q. Q., Xue, W. Z., Zou, R. X., Xu, Y., Du, Y., Wang, S., Xu, L., Chen, Y. Z., Wang, H. L., Chen, X. T. 2016b. β-Asarone Rescues Pb-Induced Impairments of Spatial Memory and Synaptogenesis in Rats. PLOS ONE, 11(12):e0167401.
Yang, Y., Xuan, L., Chen, H., Dai, S., Ji, L., Bao, Y., Li, C. 2017. Neuroprotective Effects and Mechanism of β-Asarone against A β 1-42-Induced Injury in Astrocytes. Evidence-Based Complementary and Alternative Medicine, 2017:1–14.
Zhang, Q. S., Wang, Z. H., Zhang, J. L., Duan, Y. L., Li, G. F., Zheng, D. L. 2016a. Beta-asarone protects against MPTP-induced Parkinson’s disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression. Biomedicine and Pharmacotherapy, 83:153–159.
Zhang, S., Gui, X. H., Huang, L. P., Deng, M. Z., Fang, R. M., Ke, X. H., He, Y. P., Li, L., Fang, Y. Q. 2016b. Neuroprotective Effects of β-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK/Bcl-2/Beclin-1 Pathway. Molecular Neurobiology, 53(1):83–94.
Zhang, X., Hamblin, M. H., Yin, K.-J. 2017. The long noncoding RNA Malat1: Its physiological and pathophysiological functions. RNA Biology, 14(12):1705–1714.
Zou, D. J., Wang, G., Liu, J. C., Dong, M. X., Li, X. M., Zhang, C., Zhou, L., Wang, R., Niu, Y. C. 2011. Beta-asarone attenuates beta-amyloid-induced apoptosis through the inhibition of the activation of apoptosis signal-regulating kinase 1 in SH-SY5Y cells. Die Pharmazie, 66(1):44–51.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.